Murata Tetsuhito, Maruoka Nobuyuki, Omata Naoto, Takashima Yasuhiro, Fujibayashi Yasuhisa, Yonekura Yoshiharu, Wada Yuji
Department of Neuropsychiatry, University of Fukui, Fukui, Japan.
Int J Neuropsychopharmacol. 2007 Oct;10(5):683-9. doi: 10.1017/S1461145706007218. Epub 2006 Sep 18.
We compared the potency of the interaction of three antipsychotic drugs, i.e. chlorpromazine (CPZ), haloperidol (Hal) and sulpiride (Sul), with the plasma membrane in the rat brain. CPZ loading (> or = 100 microM) dose-dependently increased both membrane permeability (assessed as [18F]2-fluoro-2-deoxy-D-glucose-6-phosphate release from brain slices) and membrane fluidity (assessed as the reduction in the plasma membrane anisotropy of 1,6-diphenyl-1,3,5-hexatriene). On the other hand, a higher concentration of Hal (1 mM) was required to observe these effects. However, Sul failed to change membrane permeability and fluidity even at a high concentration (1 mM). These results indicated the following ranking of the potency to interact with the membrane: CPZ>Hal>Sul. The difference among antipsychotic drugs in the potency to interact with the plasma membrane as revealed in the present study may be partly responsible for the difference among the drugs in the probability of inducing extrapyramidal side-effects such as parkinsonism and tardive dyskinesia.
我们比较了三种抗精神病药物,即氯丙嗪(CPZ)、氟哌啶醇(Hal)和舒必利(Sul)与大鼠脑细胞膜相互作用的强度。CPZ加载(≥100微摩尔)剂量依赖性地增加了膜通透性(通过脑片释放[18F]2-氟-2-脱氧-D-葡萄糖-6-磷酸来评估)和膜流动性(通过1,6-二苯基-1,3,5-己三烯质膜各向异性的降低来评估)。另一方面,需要更高浓度的Hal(1毫摩尔)才能观察到这些效应。然而,即使在高浓度(1毫摩尔)下,Sul也未能改变膜通透性和流动性。这些结果表明与膜相互作用的强度顺序为:CPZ>Hal>Sul。本研究揭示的抗精神病药物与质膜相互作用强度的差异可能部分解释了药物在诱发帕金森症和迟发性运动障碍等锥体外系副作用可能性上的差异。